Directed-Flow Assay Device Using Magnetic Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chromatographic and fluidic immunoassay devices face challenges such as sample preparation difficulties, contamination risks, limited sensitivity, and archival stability due to optical detection methods, which are prone to degradation and only suitable for colorless samples, and often result in false negatives or qualitative assessments.

Innovation Solution

The use of directed flow assays with superparamagnetic particles as labels, allowing for magnetic detection of analytes in a capture region on a test strip, eliminating the need for optical detection and providing standardized, reproducible results and improved sensitivity through magnetic field measurement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If optical detection methods are used in chromatographic immunoassay devices, then the device can detect analytes in colorless samples, but the results are prone to degradation, limited to qualitative assessments, and only suitable for colorless samples

Engineering Contradiction:
Improvedetection stabilityVSAvoidsample type limitation
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces optical detection methods with magnetic detection methods. Specifically, magnetic particles are used as labels instead of optical labels, and a magnetic field is applied to detect and quantify the analyte-bound magnetic particles. This substitution eliminates the limitations of optical methods (degradation, colorless sample requirement, qualitative only) while providing stable, quantitative results that work with complex samples including blood.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If optical detection methods are used, then the device can provide detection results, but the sensitivity is limited and false negatives occur

Engineering Contradiction:
Improvedetection sensitivityVSAvoidfalse negative rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the detection parameter from optical properties (absorbance, fluorescence) to magnetic properties (magnetic field strength, magnetization). Magnetic particles provide stronger and more stable signals than optical labels, enabling detection of lower analyte concentrations and reducing false negatives. The magnetic detection method allows for quantitative measurement with higher precision and reliability.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If chromatographic media are used for immunoassays, then the device can separate and detect analytes, but sample preparation is difficult and contamination risks increase

Engineering Contradiction:
Improvesample preparation simplicityVSAvoidcontamination risk
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the detection function from the chromatographic media and places it on a solid support with magnetic particles. The magnetic particles are conjugated with capture antibodies and immobilized on a solid support, allowing direct application of samples without complex chromatographic separation. This simplifies sample preparation and reduces contamination risks by eliminating the need for handling and processing through chromatographic media.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances sensitivity and accuracy, enables quantitative measurements over a wide range, and allows for rapid analysis with stable results that can be archived, reducing contamination risks and improving detection of analytes in complex samples like blood.

Implementation Method 1

The use of directed flow assays with superparamagnetic particles as labels, allowing for magnetic detection of analytes in a capture region on a test strip

Methodology Applied
Scientific EffectSuperparamagnetism: Superparamagnetism

Implementation Method 2

providing standardized, reproducible results and improved sensitivity through magnetic field measurement

Methodology Applied
Scientific EffectMagnetic field interaction: Magnetic Field

Implementation Method 3

directed flow assays

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentUS7547557B2Directed-flow assay device
Publication Date: 2009.06.16 QUANTUM DESIGN INC
  • US7547557B2 patent drawing
  • US7547557B2 patent drawing
  • US7547557B2 patent drawing

AI summary

A diagnostic assay device that directs an applied sample to the analytical membrane of a directed flow device. The device has a sample receiving port defined by layers of built-up material on one end of the test strip. The port contains the sample and specifically directs it to the membrane in a controlled fashion. Additional features include configuration of the housing in a general C-shape with the test strip spanning the opening of the C-shape to allow access by a reader device. A preferred method employs superparamagnetic particles to label the target analytes for detection and measurement by means of an electromagnetic reader device.